CG Oncology Completes Enrollment in PIVOT-006
– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the largest randomized...
Cancer
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in...
St. Baldrick’s Foundation Kicks Off Childhood Cancer Awareness Month with New ‘Send Kids’ Cancer Packing’ Initiative
Los Angeles, California--(Newsfile Corp. - September 2, 2025) - Each year, more than 15,000 families in the U.S. hear the...
TOBY Appoints Healthcare Leader Matthew Collier as Independent Director
BOSTON, Sept. 2, 2025 /PRNewswire/ -- TOBY, Inc., a leader in noninvasive multi-cancer early detections, has appointed Matthew Collier to the TOBY...
Olympus Announces U.S. Launch of Newest Imaging Platform for ENT and Urological Applications
VISERA™ S Offers Advanced Diagnostic Imaging Capabilities in a Variety of Patient Settings CENTER VALLEY, Pa., Sept. 2, 2025 /PRNewswire/...
Golden Helix and Genomenon Announce Strategic Partnership to Advance Clinical Diagnostics
BOZEMAN, Mont., Sept. 2, 2025 /PRNewswire/ -- Golden Helix, a global leader in clinical bioinformatics, today announced a strategic partnership with...
Desilo to Launch “HARVEST™,” Encrypted Data Collaboration Platform for Healthcare, in December
SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Desilo Inc., a privacy-technology startup specializing in cryptographic data collaboration, announced plans...
Amorphical Appoints Eden Ben as CEO, as Company Advances Regulatory Pathway for Nano-Amorphous Mineral-Based Therapeutics
Pipeline of Disease-Modifying Therapies Targets Hypoparathyroidism, Pancreatic Cancer, osteoporotic fractures, and Crohn's Disease NES ZIONA, Israel, Sept. 2, 2025 /PRNewswire/ -- Amorphical,...
Abridge Partnership Scales Ambient Clinical Intelligence Across Hartford HealthCare’s Clinical Enterprise
HARTFORD, Conn. & PITTSBURGH--(BUSINESS WIRE)--Abridge’s AI-powered ambient clinical intelligence platform has been selected by Hartford HealthCare, Connecticut’s most comprehensive healthcare...
Predicine Submits First Module of PMA Application to FDA for PredicineCARE™ as a Companion Diagnostic Assay in Bladder Cancer
HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Predicine, Inc., a leading molecular insights company, today announced the submission of...
Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Grand Cayman, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology...
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention...
Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt
VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is...
Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the...
Digital Pathology Market to Grow at a CAGR of 7.8% from 2025 to 2032 | SkyQuest Technology Consulting
The digital pathology market is anticipated to increase due to the global increase in chronic conditions like cancer, cardiovascular disorders,...
Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been...
Taiwan Showcases Smart Healthcare Breakthroughs at Taiwan Expo USA 2025
DALLAS, Aug. 31, 2025 /PRNewswire/ -- At Taiwan Expo USA 2025 in Dallas, the Smart Healthcare Pavilion, organized by the...
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)...
Near infrared Imaging Market worth US$2.07 billion by 2030 with 10.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 30, 2025 /PRNewswire/ -- The global Near infrared Imaging Market, valued at US$9.69 billion in 2023, stood...
Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results
Company to host webcast today at 8.00 a.m. ETGrowing portfolio of RNA delivery clients and programsAdvancing plans for partial spin-off...